{"result": "(\"entity\"<|>HOSPITAL UNIVERSITARI I POLITÈCNIC<|>ORGANIZATION<|>Hospital Universitari i Politècnic is a healthcare institution involved in the administration of parenteral nutrition protocols and patient care.)\n##\n(\"entity\"<|>NUTRICIONES PARENTERALES ADULTOS PROTOCOLIZADAS EN EL HOSPITAL<|>EVENT<|>A protocol for administering parenteral nutrition to adult patients in the hospital, established in July 2014.)\n##\n(\"entity\"<|>SENPE<|>ORGANIZATION<|>SENPE is the Spanish Society of Parenteral and Enteral Nutrition, which contributed to the consensus on parenteral nutrition mixtures.)\n##\n(\"entity\"<|>SEFH<|>ORGANIZATION<|>SEFH is the Spanish Society of Hospital Pharmacy, which collaborated on the guidelines for parenteral nutrition.)\n##\n(\"entity\"<|>GLUTAMINE AND ANTIOXIDANTS TRIAL<|>EVENT<|>A randomized trial conducted to assess the effects of glutamine and antioxidants in critically ill patients, published in the New England Journal of Medicine in 2013.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Parenteral nutrition is a medical method of providing nutrition to patients who cannot eat or absorb food through the digestive tract.)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARI I POLITÈCNIC<|>NUTRICIONES PARENTERALES ADULTOS PROTOCOLIZADAS EN EL HOSPITAL<|>The hospital implements the protocol for administering parenteral nutrition to adult patients<|>8)\n##\n(\"relationship\"<|>SENPE<|>NUTRICIONES PARENTERALES ADULTOS PROTOCOLIZADAS EN EL HOSPITAL<|>SENPE contributed to the consensus on parenteral nutrition mixtures used in the hospital's protocol<|>7)\n##\n(\"relationship\"<|>SEFH<|>NUTRICIONES PARENTERALES ADULTOS PROTOCOLIZADAS EN EL HOSPITAL<|>SEFH collaborated on the guidelines for parenteral nutrition that are part of the hospital's protocol<|>7)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARI I POLITÈCNIC<|>NUTRICIÓN PARENTERAL<|>The hospital provides parenteral nutrition to patients who cannot consume food normally<|>9)\n##\n(\"relationship\"<|>GLUTAMINE AND ANTIOXIDANTS TRIAL<|>NUTRICIÓN PARENTERAL<|>The trial is related to the study of nutritional support in critically ill patients, which includes parenteral nutrition<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: protombina, tiempo parcial de tromboplastina | Sí | 2/semana | Semanalmente |\n| Peso | Sí | Diariamente | 2-3/semana |\n| Balance de fluidos | Sí | Diariamente | Diariamente o evolución |\n| Balance nitrogenado | Variable | Variable | Variable |\n| Vitaminas, minerales, oligoelementos, equilibrio ácido-base | Según criterio clínico y duración de la NP |\n---\nEn el caso de la NPP se debe realizar los mismos controles que en la NPC. Es recomendable el empleo de un protocolo específico de prevención y diagnóstico precoz de tromboflebitis por catéter\n\n```\nLa Fe\nHospital\nUniversitari\ni Politècnic\n```\n\n82\n---\n# BIBLIOGRAFIA\n\n1. Consenso español sobre preparación de mezclas nutrientes parenterales 2008. Grupo de Nutrición de la SENPE y SEFH: Farm Hosp 2009;33 (Nº extraordinario): 81-107.\n\n2. Heyland D, Muscedere J, Wischmeyer P, Cook D, Jones G, Albert M, et all. A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients. N Engl J Med. 2013;368:1489-97\n\n3. Gomis P, Valero M A. Nutrición parenteral. En: Gil Hernández A editor. Tratado de nutrición. Tomo IV. 2ª Ed. Madrid: Editorial Médica Panamericana; 2010. p 143-69.\n\n4. Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients. Journal of Parenteral and Enteral Nutrition. 2002; 26 (1, Suppl.) 15A-1385A.\n\n5. Guidelines for the Provision and assessment of Nutrition Support Therapy in the Adult Critically ill patient. Journal of Parenteral and Enteral Nutrition: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). 2009; 33. 277-316.\n\n6. Piñeiro G, López- Gil M, Sirvent M, Calvo V, Rodríguez I, Pedraza L et al. Proceso 7. Monitorización del soporte nutricional especializado. Farm Hosp 2009; 33 (Nº extraordinario):58-63.\n\n7. Rodríguez I, Sirvent M, Calvo V, Martínez- Vázquez MJ, Vázquez A, Gomis P et all. Proceso 6. Administración. Farm Hosp 2009; 33 (Nº extraordinario):51-7.\n\n8. Sabater I, Ferriols F, Mesejo A. Nutrición parenteral. En: Mesejo A, Martínez J y Martínez C editores. Manual básico de nutrición clínica y dietética. 2ª Ed. Valencia: Nestlé Healthcare Nutrition; 2010. p 113-29.\n\n9. Standars for Nutrition Support: Adult Hospitalized patients: Nutrition in Clinical Practice. 2010: 25:403-14.\n\n10. Standards of Practice for Nutrition Support Physicans. Nutrition in Clinical Practice. 2012. 27:295-99.\n---\n| NUTRICIONES PARENTERALES ADULTOS PROTOCOLIZADAS EN EL HOSPITAL (JULIO 2014) |||||||||||||||||\n|:--|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|--:|\n| CENTRALES | N(g) | AA(g) | Glucosa(g) | Lípidos(g) | Na(mEq) | K(mEq) | Ca(mEq) | Mg(mEq) | Zn(μmol) | Acetatos(mEq) | PO4(mmol) | Cl(mEq) | Volumen(l) | Osmolaridad(mOsm/L) |\n| 1.500 kcal./8N | 8,4 | 51 | 180 | 60 | 48 | 36 | 6 | 6.6 | -- | 79 | 15 | 69 | 1,5 | 1160 |\n| INICIO/RETIRADA | 9 | 55 | 150 | -- | 70 | 60 | 9 | 10 | -- | 100 | 30 | 80 | 2 | 845 |\n| 1.500 kcal./10N | 10 | 62 | 180 | 55 | 67 | 47 | 10 | 10,6 | -- | 60 | 20 | 60 | 1,250 | 1545 |\n| 1.500 kcal./12N | 12 | 75 | 187 | 56 | 60 | 45 | 7,6 | 15 | 60 | 157 | 22,5 | 68 | 1,5 | 1800 |\n| 1.600 kcal. /14N | 13,5 | 85,4 | 165 | 60 | 52,5 | 45 | 5,3 | 6 | -- | 80 | 22,5 | 68 | 1,5 | 1310 |\n| 2000 kcal./S.E\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}